logo
‘People Are Going to Die': A Malnutrition Crisis Looms in the Wake of USAID Cuts

‘People Are Going to Die': A Malnutrition Crisis Looms in the Wake of USAID Cuts

WIRED09-07-2025
Jul 9, 2025 6:00 AM Warehouses in the US are full of foods that fight malnutrition, while kids go hungry in places like South Sudan. Photograph:Few lifesaving tools are as effective as ready-to-use therapeutic foods, known as RUTFs, which are specially designed to treat severe malnutrition and often resemble fortified peanut butter. Despite announcing a $50 million pledged to fund RUTFs earlier this summer, the Trump administration's deep cuts to foreign assistance have wreaked havoc on RUTF distribution globally, and the State Department hasn't placed orders with leading suppliers this year. Experts say the disruptions will result in more children dying from hunger.
'Stock is running critically low,' Clement Nkubizi, the country director for the nonprofit Action Against Hunger in South Sudan, tells WIRED. 'People are going to die.'
The very existence of RUTFs is a secular miracle. Considered one of the greatest innovations in preventing deaths from hunger since they were invented in the 1990s, RUTFs increase success rates treating childhood malnutrition from 25 percent to over 90 percent, according to Action Against Hunger.
Since Donald Trump took office in January, foreign aid in the United States has been gutted beyond the point of recognition. On July 1, the United States Agency for International Development (USAID) officially closed, leaving the State Department to administer some of its initiatives while wholly killing countless others. Throughout the radical dismantling of assistance programs, though, leaders like secretary of state Marco Rubio have insisted that certain lifesaving efforts would not be abandoned. Despite those assertions, critical programs have already been jettisoned, and some experts say the fatality toll from the cuts will be up to 14 million preventable deaths.
USAID directly funded around 50 percent of the world's production of RUTFs. While the Trump administration has reinstated its RUTF contracts from 2024 after initially cutting them in March, US-based providers like MANA Nutrition and Edesia are still waiting for new orders from the US government.
MANA's warehouses are still overflowing with product, up to three times the average amount of back stock the company keeps in case of acute emergencies. 'It's been sold to the US government,' says MANA cofounder David Todd Harmon. 'Nobody's picked it up.'
Rhode Island–based Edesia has been filling 2024 orders for its RUTF product, Plumpy'Nut, at a slowed-down pace. This July it finished fulfilling those contracts, and it has not received word from the State Department about future orders. In the meantime, it is filling orders from nongovernmental organizations that are far smaller than the orders that the US government formerly placed. (USAID made up 85 percent of Edesia's customer base; for MANA, it was over 90 percent.)
According to Edesia founder Navyn Salem, an order of 122,000 boxes of Plumpy'Nut is currently on its way to Sudan, but Edesia still has 185,000 boxes 'sitting there' waiting to be assigned to a country and for government officials to sign off on transportation contracts. 'For six months, we haven't been shipping anything. That means there are millions of children who are not getting what they need, and we can't catch up fast enough to reach them,' Salem says.
Edesia had to lay off 10 percent of its staff in March as USAID was dismantled; Salem says that it took 'many, many, many weeks' for the company to receive partial payment owed by the US government, and that it is still owed money for 2024 orders. 'I believe Marco Rubio when he said, 'We want to continue these programs,'' Salem says. 'Still, we have not had an order in the fiscal year.'
'We are providing $40 million to UNICEF to treat approximately 432,000 children with severe acute malnutrition, and $80 million to the World Food Programme to prevent 1.5 million children from becoming severely wasted,' a State Department spokesperson told WIRED by email when asked about the impacts of the cuts. 'The Administration is working with Edesia and other partners to broaden its partnership network, potentially adding more US-based companies, while also improving shipping efficiency and cost-effective procurement.'
Salem noted that the State Department has not communicated any of this with Edesia, and called its statement to WIRED 'not accurate, as of today.' She says she remains 'extremely hopeful' about the situation.
In the wake of broader, drastic foreign aid cuts in the United States, other nations have pared back assistance. 'People might have expected that other countries would step up and fill in the gap. We've seen the opposite,' says Action Against Hunger associate director Heather Stobaugh. 'And when we look to the philanthropic world and private foundations, there's not enough of them to fill the gap.'
So far in 2025, the UK, Germany, Switzerland, France, and Canada are among the countries further slashing aid, according to an analysis from the anti-poverty nonprofit Center for Global Development. Some private donors are helping; MANA, for example, has received $250 million in donations from a philanthropist over the past several years, which allowed it to move forward with plans to expand its warehouse space even amid the turmoil.
The disruption to the RUTF supply chain, in tandem with other aid funding cuts, is already having a dire impact on the ground. Nkubizi is seeing this unfold firsthand. Since the larger funding withdrawal meant that most of his staff have been laid off and many clinics have shuttered, patients have to travel much farther to get the help they need—often 50 to 100 kilometers. Since most travel by foot, some simply cannot make the journey.
'Now mothers have to travel a long distance with their children,' he says. When these families do reach their destinations, the RUTF supply is dwindling; after traveling all that way, they are no longer guaranteed access to the prescription foods needed to stave off death and further illness.
Nkubizi, who was born in a refugee camp in the Democratic Republic of Congo after his family fled conflict in Burundi, knows what it's like to get a chance because of US-funded RUTFs. 'I grew up as a child who needed nutritional support,' he says, noting that assistance from the United States has been viewed as a major force for good in the region. 'Catastrophe—that's the feeling going on here in Africa. People are still hoping they'll wake up and the orders will be reversed.'
Stobaugh says that the broader funding cuts have made this crisis even more acute.
'Additional cuts to the health programs are creating a perfect storm, because malnourished children' s bodies have a weakened immune system. They're not strong enough to fight off common childhood illnesses,' she says. 'We have no malnutrition treatment. We also don't have funding for treatment for TB, malaria, HIV immunization programs. With the combination of no nutrition response and no health response, these children don't stand a chance.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Weighted vests are 'great' for women in menopause. I put one to the test — and it's on sale on Amazon
Weighted vests are 'great' for women in menopause. I put one to the test — and it's on sale on Amazon

Yahoo

timean hour ago

  • Yahoo

Weighted vests are 'great' for women in menopause. I put one to the test — and it's on sale on Amazon

After a recent bone density scan alarmed me, I started looking for ways to easily incorporate strength training into my daily walks and workouts. A while back, I had a bone density scan to assess how strong my bones were, and I was shocked by the results. The early menopause I had been put into as treatment for my breast cancer, as well as the medication I was taking to limit the estrogen supply in my body, had taken its toll on my already slight frame. My bones were weaker than they had ever been, putting me at an increased risk for fractures and osteoporosis. According to Dr. Allison Rhodes, a dual board-certified doctor in internal and obesity medicine, that's a common issue women face as they age. "During menopause, women experience a decline in estrogen, which is a hormone that is key to maintaining bone density," she says. "As women, we need to look for other ways to preserve our bone health." Quick shop: My doctor insisted I immediately increase my vitamin D dosage, incorporate more calcium-rich food into my diet, and add more weight training exercises to my workouts. But I also noticed more women walking in my neighbourhood with weighted vests — and wondered if they might help improve my bone strength. I ended up buying this bestselling ZELUS Weighted Vest and spoiler alert: I'm obsessed. Keep reading for my full review and see why experts recommend weight vests for aging women. The details The strength training vest is crafted with skin-friendly neoprene fabric and weighted with durable and evenly distributed iron sand. Looking to wear this during your walks around the neighbourhood? Then you'll appreciate the detachable front zipper pockets to safely store your cell phone and keys. There's also a rear elastic mesh pocket for additional on-the-go storage. The reflective stripes mean added security during your evening runs. The cushioned shoulder straps and non-chafing material make the vest an ideal accessory for even the longest workouts. The adjustable buckle straps allow for a more custom fit, and the vest itself is available in various weights from 6 lbs to 30 lbs. What I like about it I'm all about easy ways to make my workouts count more: I wore this vest daily while walking on the highest incline on the treadmill at a very brisk pace — and according to my watch, burned more calories than when I wasn't wearing it. I stood taller on the treadmill, was able to go at a faster clip, and overall just felt stronger. I'm not a super big person (I weigh 115 lbs and am about 5'5") and went with the 6 lb size, but just having this weighted vest on my shoulders made me feel more grounded, which meant I could work out for longer. You can wear it anywhere: I also wore it while I was cleaning the house, doing laundry and working at my computer — and noticed I sat up taller and kept my muscles more engaged. Your abs will thank you for it: It even helped with my ab workouts. I wore it while holding my two-minute front and side planks, and I felt more of a burn in my belly. Great for anyone who has had a double mastectomy: As a breast cancer survivor who had a double mastectomy, I am very cautious of anything resting on that sensitive chest area. The vest fell perfectly on my body. It didn't feel heavy or uncomfortable, and I often forgot I even had it on. The buckle in the front can be easily adjusted, and for my size, the 6 lbs of weight offered just the right amount of resistance. Room for improvement I wasn't thrilled with how it smelled: OK, functionally, this vest was amazing — but it smelled awful when it came out of the package — to the point that the chemical scent distracted me from my workouts the first few times I wore it. Even now, after wearing it regularly for the past two months, the smell still lingers. I guess you could rub it with a dryer sheet or some other deodorizer, but I don't think you should be required to do that to improve the scent. It's not a deal breaker, but it's something to be mindful of, especially if you're sensitive to smells. What other shoppers are saying ⭐️4.2/5 stars 💬 8,500+ reviews 🏅"Easily adds intensity to a simple walk." Reviewers are "impressed" with the vest, with one saying that it "really helps you burn" extra calories in a "shorter amount of time." $37 $47 at Amazon "Obsessed with this vest!" adds another shopper, who loves that the vest doesn't "flop" around when running. Another person said the "comfortable" vest is "great for muscles and bones" and loves wearing it daily while cooking and doing housework. They say it also "makes [their] posture better." This vest is a total "game changer" said one customer, stating the impact of the vest was even "greater" than they expected. "Don't sleep on" getting a weighted vest, they advised. However, if you have a large chest, this may not be for you. One shoppers cautioned it's best for "flat chested" users and, like me, said it "definitely smelled like plastic" after they opened the package. Are weighted vests good for you? Do weighted vests work? Experts weigh in Tara De Leon, a personal trainer and menopause coach, says that "weighted vests are particularly great for women in menopause because they improve bone density, enhance muscular strength, support joint health, improve balance, decreases fall risk and improve posture." $37 $47 at Amazon She adds they do that "all without the excessive strain that high impact exercise can cause," and says she likes them more than ankle or wrist weights, which "can throw off your gait." Rhodes also says she recommends the vest for women in menopause — as well as peri- and post-menopausal people, because "adding a weighted vest can not only turn a simple walk into a workout, but one that counts as resistance training." Why is this important? According to Rhodes, both men and women can start to experience muscle loss as early as in their late 30s and 40s (yikes!). In order to prevent injury and illness, "...maintaining muscle mass and strength is critical for both men and women to ensure optimal mobility and balance as we age," she says. But that said, experts do say there are a few key things to keep in mind before you buy a weighted vest to ensure you won't injure yourself. "Weighted vests should fit snugly and evenly distribute weight to limit risk of injury," Rhodes cautions. She says the weight of the vest should be dependent on your current body weight, and recommends starting with a vest that's 5-10 per cent your weight. For example, if you weigh 200 lbs., a good starting point would be a 10-lb. vest. It's also a good idea to start slowly when working a weighted vest into your routine. Michael Betts, a personal trainer with more than 30 years of experience, recommends "add[ing] weighted vest training gradually into an existing exercise routine that includes strength training and balance work." Is there anyone who should avoid weighted vests? Dr. Chris Mohr, a fitness and nutrition advisor at BarBend, advises that "people with existing joint issues should be cautious, as excessive weight can increase strain, particularly on the knees and lower back." All the experts agree that if you have osteoporosis, arthritis or other health conditions, you should consult your doctor before trying out a weighted vest. Should you buy it? For me, working out while wearing a weighted vest has become my new normal. I love the way it makes me feel, the endurance it gives me, and the added boost to my metabolism it provides. It's super comfortable, and the offensive odour it had when I first got it has almost worn off. Mind you, I have no plans to go up in weight, and for my smaller frame, the 6 lb vest is the perfect fit. I'm inclined to agree with one reviewer and call the ZELUS weighted vest a "game changer." While experts agree that it can make a major impact to your workout, they do caution that if you have existing health issues, you should consult your doctor before adding one to your routine. Meet the experts Allison Rhodes, MD, dual board-certified in internal medicine and obesity medicine, The Ohio State University Wexner Medical Center Tara De Leon, NSCA Personal Trainer of the Year and menopause coach Michael Betts, personal trainer and director at TRAINFITNESS Chris Mohr, PHD, RD, Fitness and Nutrition Advisor at BarBend

Earnings To Watch: Pediatrix Medical Group (MD) Reports Q2 Results Tomorrow
Earnings To Watch: Pediatrix Medical Group (MD) Reports Q2 Results Tomorrow

Yahoo

timean hour ago

  • Yahoo

Earnings To Watch: Pediatrix Medical Group (MD) Reports Q2 Results Tomorrow

Pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) will be reporting earnings this Tuesday before market open. Here's what investors should know. Pediatrix Medical Group beat analysts' revenue expectations by 1.6% last quarter, reporting revenues of $458.4 million, down 7.4% year on year. It was a very strong quarter for the company, with an impressive beat of analysts' same-store sales estimates and a solid beat of analysts' EPS estimates. Is Pediatrix Medical Group a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Pediatrix Medical Group's revenue to decline 7.9% year on year to $464.4 million, a deceleration from its flat revenue in the same quarter last year. Adjusted earnings are expected to come in at $0.42 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Pediatrix Medical Group has missed Wall Street's revenue estimates four times over the last two years. Looking at Pediatrix Medical Group's peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. The Ensign Group delivered year-on-year revenue growth of 18.5%, beating analysts' expectations by 0.7%, and CVS Health reported revenues up 8.4%, topping estimates by 5.1%. The Ensign Group traded up 8.7% following the results while CVS Health's stock price was unchanged. Read our full analysis of The Ensign Group's results here and CVS Health's results here. Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. Pediatrix Medical Group is down 10.9% during the same time and is heading into earnings with an average analyst price target of $17.14 (compared to the current share price of $11.98). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

FDA Calls for Better Opioid Safety Labeling
FDA Calls for Better Opioid Safety Labeling

Medscape

timean hour ago

  • Medscape

FDA Calls for Better Opioid Safety Labeling

The FDA is requiring manufacturers of opioid pain medications to update safety labels to better emphasize risks linked to their long-term use, the agency announced in a new Drug Safety Communication. The changes are based on observations from a May meeting between the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee, which met to discuss two postmarketing requirement studies that assessed risk for abuse, addiction, and overdose in long-term use of opioid analgesics. One of the observational studies showed that over 12 months of use, 1%-6% of the more than 2000 total participants met criteria for opioid addiction, 9% met criteria for prescription opioid abuse, and 22% met criteria for prescription opioid misuse. In the second study, 5-year cumulative incidence estimates for opioid overdose-related death ranged from 1.5%-4.0%. In addition, 17% of first opioid overdoses over the entire 5-11 year study period were fatal. The new safety-labeling requirements are a result of these findings, committee and public comments from the meeting, and recognition that there is currently an 'absence of adequate and well-controlled studies on long-term opioid effectiveness,' the FDA noted in a press release. 'The death of almost 1 million Americans during the opioid epidemic has been one of the cardinal failures of the public health establishment,' FDA commissioner Marty Makary, MD, said in the release. 30-Day Warning The FDA has also called for a new prospective, randomized controlled trial to be conducted that will focus primarily on assessing risks and benefits of opioids used over the long term. For now, the updated labeling should include a better explanation of risks, stronger warnings about higher doses, clarification about use limits, an emphasis that long-acting or extended-release opioids should only be used if shorter-acting opioids or other medications have proven inadequate, and a reminder about serious harm that can come if a patient who becomes physically dependent does not stop opioid use. Additionally, the revised labels should provide information on possible opioid-related problems with the esophagus; on opioid overdose reversal agents; on toxic leukoencephalopathy, which can occur after overdose; and on negative drug-drug interactions, including gabapentinoids. 'This long-overdue labeling change is only part of what needs to be done — we also need to modernize our approval processes and postmarket monitoring,' Makary said. The release noted that OxyContin's drug application was first approved without supportive long-term use data. The FDA added that manufacturers have 30 days to submit the newly required labeling updates for review.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store